Morgan Stanley has recently initiated Recursion Pharmaceuticals Inc (RXRX) stock rating, as announced on May 22, 2023, according to Finviz. Earlier, on March 16, 2023, Needham had initiated the stock ...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...
On Thursday, Immunic Inc (IMUX) stock saw a modest uptick, ending the day at $1.59 which represents a slight increase of $0.05 or 3.25% from the prior close of $1.54. The stock opened at $1.54 and ...